Clinical Trials Browser

Solid Tumor

NCT05844306 2025-11-19

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

Phase NA Suspended

20 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06503146 2025-11-12

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Phase 2 Recruiting

320 enrolled

CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT06383598 2025-07-15

PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

50 enrolled

Other solid neoplasm

Solid Tumor

NCT06429891 2024-08-22

Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

Phase NA Recruiting

50 enrolled

Other solid neoplasm

Solid Tumor

NCT05322512 2023-11-29

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Phase NA Unknown

20 enrolled

Other solid neoplasm

Solid Tumor

NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Phase 1 Completed

19 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT02070406 2019-02-28

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Phase 1 Terminated

4 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Phase 2 Completed

7 enrolled 6 charts

BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

NCT00019565 2016-09-26

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Phase 1 Completed

53 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00816335 2016-04-04

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Phase EARLY_PHASE1 Completed

65 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors

Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

18F-FSPG PET/CT for Cancer Patients on Therapy

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors